CME Group (NASDAQ:CME) Given New $258.00 Price Target at Oppenheimer

CME Group (NASDAQ:CME) had its price target raised by Oppenheimer from $245.00 to $258.00 in a research note published on Thursday, Benzinga reports. Oppenheimer currently has an outperform rating on the financial services provider’s stock.

Several other equities research analysts also recently weighed in on CME. Piper Sandler raised their target price on shares of CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a research note on Tuesday, October 8th. Barclays lifted their price objective on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday. TD Cowen began coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective for the company. The Goldman Sachs Group boosted their target price on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. According to MarketBeat, CME Group has an average rating of “Hold” and an average price target of $222.07.

CME Group Stock Down 1.0 %

CME stock traded down $2.41 during trading on Thursday, hitting $227.28. 216,026 shares of the company’s stock traded hands, compared to its average volume of 1,927,291. The firm has a market capitalization of $81.84 billion, a P/E ratio of 26.13, a PEG ratio of 7.76 and a beta of 0.55. The business has a fifty day simple moving average of $218.08 and a two-hundred day simple moving average of $208.66. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group has a 1 year low of $190.70 and a 1 year high of $230.36.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s revenue was up 18.4% compared to the same quarter last year. During the same period last year, the firm earned $2.25 earnings per share. Sell-side analysts anticipate that CME Group will post 10.04 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.02%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Transactions at CME Group

In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

Large investors have recently bought and sold shares of the business. Brookstone Capital Management boosted its holdings in CME Group by 3.4% in the 1st quarter. Brookstone Capital Management now owns 27,230 shares of the financial services provider’s stock valued at $5,862,000 after purchasing an additional 903 shares during the last quarter. Artemis Investment Management LLP boosted its holdings in CME Group by 32.6% in the 1st quarter. Artemis Investment Management LLP now owns 55,342 shares of the financial services provider’s stock valued at $11,908,000 after purchasing an additional 13,598 shares during the last quarter. Trifecta Capital Advisors LLC boosted its holdings in CME Group by 2.6% in the 1st quarter. Trifecta Capital Advisors LLC now owns 6,175 shares of the financial services provider’s stock valued at $1,329,000 after purchasing an additional 159 shares during the last quarter. Hennion & Walsh Asset Management Inc. boosted its holdings in CME Group by 83.0% in the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 7,630 shares of the financial services provider’s stock valued at $1,643,000 after purchasing an additional 3,461 shares during the last quarter. Finally, WoodTrust Financial Corp boosted its holdings in CME Group by 9.8% in the 1st quarter. WoodTrust Financial Corp now owns 1,654 shares of the financial services provider’s stock valued at $356,000 after purchasing an additional 147 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.